The SMAD4 (DPC4) gene was initially isolated as a candidate tumor suppresso
r from the convergent site of homozygous deletions on 18q in a panel of pan
creatic carcinoma cell lines. It encodes a common cytoplasmic signaling mol
ecule shared by the transforming growth factor-p, activin, and bone morphog
enic pathways. We recently inactivated its mouse homologue Smad4 and demons
trated its role in the malignant progression of benign adenomas to invasive
adenocarcinomas by analyzing mice with Ape and Smad4 compound mutations, A
lthough simple Smad4 homozygotes were embryonically Lethal, the heterozygot
es were fertile and appeared normal up to the age of 1 year. Upon further i
nvestigation, however, they have developed inflammatory polyps in the gland
ular stomach and duodenum, By PCR genotyping and immunohistochemical staini
ng, the wild-type Smad4 allele has been lost in the polyp epithelial cells,
i.e., loss of heterozygosity, On the other hand, we have not found any mut
ations in such genes as K-Ras, H-Ras, N-Ras, p53, or PTEN. Histologically,
the polyps are similar to human juvenile polyps showing moderate stromal ce
ll proliferation and infiltrations by eosinophils and plasma cells. In addi
tion, foci of adenocarcinoma with signet ring cells are also found. These r
esults are consistent with a recent report that germ-line SMAD4 mutations a
re found in a subset of familial juvenile polyposis.